The GBD study offers a powerful resource to understand the changing health challenges facing people across the world in the 21st century. Led by the Institute for Health Metrics and Evaluation (IHME), the GBD study is the most comprehensive worldwide observational epidemiological study to date. By tracking progress within and between countries GBD provides an important tool to inform clinicians, researchers, and policy makers, promote accountability, and improve lives worldwide.
Published in October 2020, The Lancet’s special issue on GBD includes the most up-to-date global health data from 2019 with the latest analysis focused on five key themes: demographics, diseases and injuries, risk factors, population forecasting, and universal health coverage. Further information is also available via The Lancet's GBD Resource Centre.